People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, over-the-counter (OTC) and prescription options are available.

It belongs to a group of drugs called proton pump inhibitors. These medications work ... it’s an exact copy of the active ingredient in a brand-name medication. The brand-name medication that ...

Proton pump inhibitors (PPIs), for example ... When they debuted in 1988, they quickly became popular with brand names like Prilosec, Prevacid and Nexium. Current market sales exceed $3 billion ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - like these popular medications.

Here are some gluten-free brands, according to sources recommended by the Celiac ... The active ingredients cimetidine and famotidine are examples of H2 blockers. Proton-pump inhibitors also reduce ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...

[44] Proton pump inhibitors are well-tolerated drugs. There is no clear evidence of increased toxicity among poor metabolizers, despite a markedly elevated AUC. [22] The risk of minor adverse ...

particularly proton pump inhibitors, can bring about a whole host of other health risks and serious cardiovascular complications. Understanding how these medications affect the heart and one's ...

6 th Avenue, Tucson, Arizona 85723-0001, USA; Ronnie.Fass{at}va.gov Patients with gastro-oesophageal reflux disease (GORD) who are not responding to proton pump inhibitors (PPIs) given once daily are ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...